Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
BRIEF-Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand Oct 8 (Reuters) - Pharmala Biotech Holdings Inc MDMA.CD:
PHARMALA BIOTECH HOLDINGS INC: RUA BIOSCIENCE AND PHARMALA BIOTECH PARTNER TO SUPPLY MEDICINAL MDMA IN NEW ZEALAND
PHARMALA BIOTECH - RUA TO IMPORT, DISTRIBUTE AND SELL PHARMALA'S LANEO MDMA IN NEW ZEALAND
PHARMALA BIOTECH - RUA TO SUPPLY 40 MG LANEO MDMA CAPSULES TO AUTHORISED PRESCRIBERS IN NEW ZEALAND
PHARMALA BIOTECH - FIRST SHIPMENT TO BE SUPPLIED ON CONSIGNMENT BASIS WITH MINIMAL UPFRONT CAPITAL
PHARMALA BIOTECH HOLDINGS: ON SEPT 1, CO & VERIDION SIGNED TERMINATION & MUTUAL RELEASE AGREEMENT
PHARMALA BIOTECH - TERMINATION ENDS EXCLUSIVE NEW ZEALAND DISTRIBUTION AGREEMENT DATED SEPTEMBER 21, 2025
Source text: ID:nGNX9NyvTZ
Further company coverage: MDMA.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth